High morbidity risks for unspecified functional psychosis and schizophrenia. Evidence for GABAergic and glutamatergic transmission abnormalities in schizophrenia. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Recent developments in the neuropharmacology of schizophrenia. J. Health -Syst.
Ketamine activates psychosis in schizophrenia and alters blood flow in human limbic cortex.
Current status and future directions. International Clinical Psychopharmacology, Vol. The new generation of antipsychotic drugs. Abnormal smooth pursuit eye movements in schizophrenic patients are associated with the deficit syndrome. The effects of ketamine on memory and other cognitive functions in schizophrenic patients.